Finance Home - My Yahoo - Yahoo! - Help

Thursday, January 7, 2010, 11:06PM ET - U.S. Markets Closed. Dow  0.31% Nasdaq  0.05%

GALAPAGOS (GLPGA.AS)

On Jan 13: 4.85   0.13 (2.61%)

MORE ON GLPGA.AS

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Headlines Get Headlines for:
Change Display [ hide $$  edit ] Wed, Dec 16, 2009 • Galapagos and GlaxoSmithKline Broaden Arthritis Alliance Marketwire (Wed, Dec 16) Tue, Dec 8, 2009 • Galapagos Receives EUR 4 M Milestone for First Clinical Trial in GlaxoSmithKline Alliance Marketwire (Tue, Dec 8) Mon, Dec 7, 2009 • Galapagos CEO increases shareholding Marketwire (Mon, Dec 7) Thu, Dec 3, 2009 • Galapagos achieves multiple milestones in rheumatoid arthritis alliance Marketwire (Thu, Dec 3) Thu, Nov 26, 2009 • Galapagos receives EUREKA innovation label and OSEO funding Marketwire (Thu, Nov 26) Tue, Nov 17, 2009 • Galapagos initiates Nanocort(R) Phase II clinical trial for multiple sclerosis Marketwire (Tue, Nov 17) Fri, Nov 13, 2009 • Galapagos Business Update Marketwire (Fri, Nov 13) Fri, Oct 16, 2009 • Galapagos successfully completes placement of 2,125,925 new ordinary shares Marketwire (Fri, Oct 16) Thu, Oct 15, 2009 • Galapagos announces offering of new ordinary shares Marketwire (Thu, Oct 15) Wed, Oct 14, 2009 • Galapagos expands strategic alliance in metabolic disease with Merck & Co., Inc. Marketwire (Wed, Oct 14) Thu, Sep 24, 2009 • Galapagos announces expanded drug discovery collaboration with Schering-Plough Marketwire (Thu, Sep 24) Thu, Sep 17, 2009 • Galapagos collaborates with Charley's Fund, Nash Avery Foundation to develop SARM candidate drug for Duchenne muscular dystrophy Marketwire (Thu, Sep 17) Thu, Sep 10, 2009 • Galapagos initiates second Phase I clinical trial for GLPG0259 Marketwire (Thu, Sep 10) Thu, Aug 6, 2009 • Galapagos Successfully Completes First Phase I Study for GLPG0259 Marketwire (Thu, Aug 6) Thu, Jul 23, 2009 • Galapagos achieves milestone in osteoporosis collaboration with Lilly Marketwire (Thu, Jul 23) Tue, Jul 7, 2009 • Galapagos delivers second pre-clinical candidate in alliance with GlaxoSmithKline and receives EUR 5.2 million in milestone payments Marketwire (Tue, Jul 7) Tue, Jun 30, 2009 • Galapagos Awarded Innovative Enterprise Qualification in France Marketwire (Tue, Jun 30) Tue, Jun 16, 2009 • Galapagos Initiates Clinical Studies With GLPG0187, a Candidate Drug for Bone Metastasis Marketwire (Tue, Jun 16) Wed, Jun 3, 2009 • Galapagos announces appointment of new CFO and Board Member; creates new warrant plan Marketwire (Wed, Jun 3) Thu, May 28, 2009 • Galapagos achieves milestone payment in rheumatoid arthritis alliance Marketwire (Thu, May 28) Older Headlines - Download Recent Headlines View headlines from: Thu, May 28, 2009Thu, May 21, 2009Thu, May 14, 2009Thu, May 7, 2009Thu, Apr 30, 2009Thu, Apr 23, 2009Thu, Apr 16, 2009Thu, Apr 9, 2009Thu, Apr 2, 2009Thu, Mar 26, 2009 Add GLPGA.AS News to My Yahoo!:
Add to Portfolio     Set Alert     Email to a Friend Get Headlines for Another Symbol: Symbol Lookup • Stocks In Play • Story Stocks • Full Coverage